Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01962740 · ClinicalTrials.gov registry record · NA
Serial Evaluation of Drug-Eluting Stents Using OCT (STRUT-OCT)
A NA study, sponsored by North Texas Veterans Healthcare System.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT01962740 is a NA study that was terminated before completion, run by North Texas Veterans Healthcare System. The registered enrollment target is 3 participants.
The verdict
NCT01962740, a NA study, was terminated before completion, sponsored by North Texas Veterans Healthcare System.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
The study is proposed as a 48-patient randomized-controlled pilot study that will use Optical Coherence Tomography (OCT) imaging to compare stent strut coverage and malapposition of three second-generation Drug Eluting Stents (DES) \[Xience EES (Abbott Vascular, Santa Clara, CA), Resolute Integrity ZES (Medtronic, Minneapolis, MN) and Promus Element EES (Boston Scientific, Natick, MA)\] at 6 weeks post implantation. Study Hypothesis is that the rates of stent strut coverage and malapposition of the Xience EES, Promus EES and will be similar to each other and improved (higher rates of stent strut coverage and lower rates of malapposition) compared to the Resolute ZES at 6 weeks post-implantation.
Interventions
- DEVICE Drug-eluting stent implantation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2013-09 |
| Est. Completion | 2015-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01962740
The ClinicalTrials.gov registry entry for NCT01962740 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is North Texas Veterans Healthcare System, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Drug-eluting stent implantation is the first listed.
NCT01962740 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01962740 about?
NCT01962740 is a clinical study titled "Serial Evaluation of Drug-Eluting Stents Using OCT (STRUT-OCT)". The study is proposed as a 48-patient randomized-controlled pilot study that will use Optical Coherence Tomography (OCT) imaging to compare stent strut coverage and malapposition of three second-generation Drug Eluting Stents (DES) \[Xience EES (Abbott Vascular, Santa Clara, CA), Resolute Integrity ...
What is the current status of trial NCT01962740?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2013-09. Estimated completion is 2015-03.
What interventions are being tested in trial NCT01962740?
The interventions under investigation include: Drug-eluting stent implantation (DEVICE).
Who is sponsoring clinical trial NCT01962740?
This trial is sponsored by North Texas Veterans Healthcare System, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.